In the first part of the Linkage to Care episode, we hear from the Center for Liver Health (CUHK), a non-profit organization in Hong Kong, about their work to increase public understanding of viral hepatitis and provide education about liver diseases.
In this webinar, we learn from Prof. Grace LH Wong, Director of Medical Data Analytic Center & Consultant Hematologist at CUKH as she shares about the “New Life New Liver” Program that CUHK has been carrying out since 2009 to expedite linkage to care among ex-intravenous drug users.
For more information about Center for Liver Health (CUHK), visit:
Website: www.cuhkmc.hk/
Facebook: / cuhkmedicalcentre
Instagram: / cuhkmedicalcentre
For more information about Gilead, visit:
Website: www.gilead.com
Stories@Gilead: stories.gilead.com
Twitter: / gileadsciences
LinkedIn: / gileadsc .
Instagram: / gileadsciences
Facebook: / gileadsciences
About Gilead
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
This webinar episode was created and fully funded by Gilead Sciences, Inc. GILEAD, the GILEAD logo, and the & design are trademarks of Gilead Sciences, Inc. © 2023 Gilead Sciences, Inc. All rights reserved.